Although 27% of postmenopausal women were taking HRT in 1999, Kennedy said, that trend began to reverse after the publication ...
Q: My doctor just told me that I’m now considered obese. A week ago, I wasn’t — and I haven’t gained any weight. What’s going ...
With a favourable safety profile and consistent activity across tumour types, agenT-797 is now poised to enter phase 2 trials. MiNK believes the therapy could redefine treatment for patients with ...
Dr. Matthew Rettig and his research team have been awarded a Clinical Cancer Research Center grant from the U.S. Department of Veterans Affairs to establish a new clinical cancer research center that ...
New review of research shows benefits outweigh risks for women who start treatment within 10 years of menopause onset After [ ...
Purdue Pharma L.P. ("Purdue") today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pipeline drug tinostamustine for the treatment of ...
Positron emission tomography (PET), when combined with computed tomography (CT), has become one of the most powerful ...